ORX:STO
Orexo AB
SEK 0.99
arrow_downward
-1.29%(-0.013) 1D
Nov 19, 12:01:43 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 1.03
High
SEK 1.06
Low
SEK 0.94
Mkt. cap
348.42M
Avg. vol.
771.26K
Volume
418.83K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.03
High
SEK 1.06
Low
SEK 0.94
Mkt. cap
348.42M
Avg. vol.
771.26K
Volume
418.83K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
TradingView
·
1 hour ago
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
BigGo Finance
·
1 hour ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
Yahoo Finance
·
1 hour ago
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Business Insider
·
1 hour ago
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com